As determined by pan-cancer prognostic analyses, high expression of CX3CL1 was substantially associated with improved OS, DSS, and PFI in CESC and KICH, OS and DSS in KIRC, and DSS and PFI in LUAD. The gene discussed is CX3CL1; the disease is cancer.